2nd Liquid Biopsy Surveillance and Early Detection Summit

Optimize Surveillance with Sensitive, Standardized Analytical Assays, Clinically Validated MRD Tests and Reliable ctDNA Surrogate Biomarkers to Detect Disease Earlier and Improve Patient Outcomes

Time: 9:00 AM – 6:00 PM

Venue Details: Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States

Prices:
Drug Developers and Academics Conference Pass: USD 0.50,
Vendors Conference Pass: USD 3799.00

Speakers: Aadel Chaudhuri, Advisory Council, Washington University School of Medicine in St. Louis, Aleksandra Markovets, Director, Oncology Bioinformatics, AstraZeneca, Amanda Acerbi, Global Director, Precision Medicine, Janssen, Angela Silvestro, Director, Companion Diagnostics, GSK, David Yu, Director, Translational Sciences and Diagnostics, Bristol Myers Squibb, Feng Liu, Director, Translational Oncology, Pfizer, Gary Kelloff, Special Advisor, DCTD, National Cancer Institute, NIH, and more